Page last updated: 2024-08-21

ethyl pyruvate and Inflammatory Response Syndrome, Systemic

ethyl pyruvate has been researched along with Inflammatory Response Syndrome, Systemic in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Altun, G; Civelek, A; Hemşinli, D; Menteşe, A; Pulathan, Z; Yuluğ, E1
Cai, B; Deitch, EA; Grande, D; Ulloa, L1
Czura, CJ; Fink, MP; Halperin, D; Ochani, M; Tanovic, M; Tracey, KJ; Ulloa, L; Yang, H; Yang, R1

Other Studies

3 other study(ies) available for ethyl pyruvate and Inflammatory Response Syndrome, Systemic

ArticleYear
Role of ethyl pyruvate in systemic inflammatory response and lung injury in an experimental model of ruptured abdominal aortic aneurysm.
    BioMed research international, 2014, Volume: 2014

    Topics: Aneurysm, Ruptured; Animals; Aortic Aneurysm, Abdominal; Disease Models, Animal; Humans; Lung Injury; Male; Pyruvates; Rats; Reperfusion Injury; Systemic Inflammatory Response Syndrome

2014
Anti-inflammatory resuscitation improves survival in hemorrhage with trauma.
    The Journal of trauma, 2009, Volume: 66, Issue:6

    Topics: Animals; Anti-Inflammatory Agents; Disease Models, Animal; Fluid Therapy; Hemorrhage; Male; Pyruvates; Rats; Rats, Sprague-Dawley; Resuscitation; Systemic Inflammatory Response Syndrome; Tumor Necrosis Factor-alpha; Wounds and Injuries

2009
Ethyl pyruvate prevents lethality in mice with established lethal sepsis and systemic inflammation.
    Proceedings of the National Academy of Sciences of the United States of America, 2002, Sep-17, Volume: 99, Issue:19

    Topics: Animals; Cell Line; Endotoxemia; Enzyme Activation; HMGB1 Protein; Lipopolysaccharides; Macrophages; Male; Mice; Mice, Inbred BALB C; Mitogen-Activated Protein Kinases; NF-kappa B; p38 Mitogen-Activated Protein Kinases; Pyruvates; RNA, Messenger; Sepsis; Signal Transduction; Systemic Inflammatory Response Syndrome; Tumor Necrosis Factor-alpha

2002